Insider: Van Plew Daniel P EVP & General Mgr, Industrial - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 29,397 | 0 | 29,397 |
| Value | $16,395,588.81 | $0.00 | $16,395,588.81 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/14/2024 | DDS | 750 | Direct | COM | $939.60 | $704,700.00 | 29,397 |
| 02/14/2024 | DDS | 4,261 | Direct | COM | $940.44 | $4,007,214.84 | 25,136 |
| 02/14/2024 | DDS | 226 | Direct | COM | $938.13 | $212,017.38 | 30,147 |
| 02/14/2024 | DDS | 439 | Direct | COM | $937.94 | $411,755.66 | 30,373 |
| 02/14/2024 | DDS | 200 | Direct | COM | $951.77 | $190,354.00 | 20,378 |
| 02/14/2024 | DDS | 2,691 | Direct | COM | $943.51 | $2,538,985.41 | 22,170 |
| 02/14/2024 | DDS | 275 | Direct | COM | $941.41 | $258,887.75 | 24,861 |
| 02/14/2024 | DDS | 620 | Direct | COM | $944.30 | $585,466.00 | 21,550 |
| 02/14/2024 | DDS | 375 | Direct | COM | $950.45 | $356,418.75 | 20,578 |
| 02/14/2024 | DDS | 150 | Direct | COM | $948.70 | $142,305.00 | 21,065 |
| 02/14/2024 | DDS | 112 | Direct | COM | $949.07 | $106,295.84 | 20,953 |
| 02/14/2024 | DDS | 240 | Direct | COM | $947.81 | $227,474.40 | 21,215 |
| 02/14/2024 | DDS | 95 | Direct | COM | $945.81 | $89,851.95 | 21,455 |
| 08/24/2023 | DDS | 300 | Direct | COM | $837.53 | $251,259.00 | 26,642 |
| 08/24/2023 | DDS | 667 | Direct | COM | $838.37 | $559,192.79 | 25,975 |
| 08/24/2023 | DDS | 138 | Direct | COM | $835.67 | $115,322.46 | 27,567 |
| 08/24/2023 | DDS | 148 | Direct | COM | $839.28 | $124,213.44 | 25,827 |
| 08/24/2023 | DDS | 625 | Direct | COM | $836.32 | $522,700.00 | 26,942 |
| 08/24/2023 | DDS | 46 | Direct | COM | $840.74 | $38,674.04 | 25,781 |
| 08/24/2023 | DDS | 2,534 | Direct | COM | $844.27 | $2,139,380.18 | 21,508 |
| 08/24/2023 | DDS | 759 | Direct | COM | $843.31 | $640,072.29 | 24,042 |
| 08/24/2023 | DDS | 617 | Direct | COM | $842.66 | $519,921.22 | 24,801 |
| 08/24/2023 | DDS | 363 | Direct | COM | $841.15 | $305,337.45 | 25,418 |
| 11/07/2022 | DDS | 100 | Direct | COM | $742.79 | $74,279.00 | 38,364 |
| 11/07/2022 | DDS | 2,032 | Direct | COM | $744.61 | $1,513,047.52 | 35,232 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research